Abstract
Executive Summary
1.
In adult cardiac surgery with cardiopulmonary bypass (CPB), avoiding hyperthermic perfusion (>37 °C) is recommended to reduce the risk of cardiac surgery–associated acute kidney injury (CSA-AKI). (Class of Recommendation: I, Level of Evidence: B-R)
2.
In adult cardiac surgery with CPB, a goal-directed oxygen delivery strategy is recommended to reduce the risk of CSA-AKI. (Class of Recommendation: I, Level of Evidence: B-R)
3.
In adult cardiac surgery with CPB, it is reasonable to adopt the Kidney Disease Improving Global Outcomes (KDIGO) practice guidelines for patients at high risk of AKI to reduce the risk of CSA-AKI (Class of Recommendation IIA; Level of Evidence B-R).
4.
In adult cardiac surgery with CPB, fenoldopam may be reasonable to reduce the risk of CSA-AKI, as long as hypotension is avoided (Class of Recommendation: IIB, Level of Evidence: B-R).
5.
In adult cardiac surgery with CPB, it might be reasonable to use minimally invasive extracorporeal circulation (MiECC) techniques to reduce the risk of CSA-AKI. (Class of Recommendation: IIB, Level of Evidence: B-R)
6.
In adult cardiac surgery with CPB, dopamine infusion alone, during CPB and the perioperative period, is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: A)
7.
In adult cardiac surgery with CPB, mannitol is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: B-R)
1.
In adult cardiac surgery with cardiopulmonary bypass (CPB), avoiding hyperthermic perfusion (>37 °C) is recommended to reduce the risk of cardiac surgery–associated acute kidney injury (CSA-AKI). (Class of Recommendation: I, Level of Evidence: B-R)
2.
In adult cardiac surgery with CPB, a goal-directed oxygen delivery strategy is recommended to reduce the risk of CSA-AKI. (Class of Recommendation: I, Level of Evidence: B-R)
3.
In adult cardiac surgery with CPB, it is reasonable to adopt the Kidney Disease Improving Global Outcomes (KDIGO) practice guidelines for patients at high risk of AKI to reduce the risk of CSA-AKI (Class of Recommendation IIA; Level of Evidence B-R).
4.
In adult cardiac surgery with CPB, fenoldopam may be reasonable to reduce the risk of CSA-AKI, as long as hypotension is avoided (Class of Recommendation: IIB, Level of Evidence: B-R).
5.
In adult cardiac surgery with CPB, it might be reasonable to use minimally invasive extracorporeal circulation (MiECC) techniques to reduce the risk of CSA-AKI. (Class of Recommendation: IIB, Level of Evidence: B-R)
6.
In adult cardiac surgery with CPB, dopamine infusion alone, during CPB and the perioperative period, is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: A)
7.
In adult cardiac surgery with CPB, mannitol is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: B-R)
Original language | English |
---|---|
Pages (from-to) | 34-42 |
Number of pages | 9 |
Journal | Annals of Thoracic Surgery |
Volume | 115 |
Issue number | 1 |
Early online date | 20 Dec 2022 |
DOIs | |
Publication status | Published - Jan 2023 |
Keywords
- cardiac disease
- comorbidities
- kidney disease
- guidelines